Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effectsPeter A. McSweeney, Rainer Storb, Dietger Niederwieser et al.|Blood|2001Cited by 1.4k
Ipilimumab for Patients with Relapse after Allogeneic TransplantationMatthew S. Davids, Robert J. Soiffer, Haesook T. Kim et al.|New England Journal of Medicine|2016Cited by 595
Myeloablative Autologous Stem-Cell Transplantation for Severe SclerodermaKeith Sullivan, Daniel E. Furst, E. William St. Clair et al.|New England Journal of Medicine|2018Cited by 584
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myelomaDavid G. Maloney, Rainer Storb, Arthur J. Molina et al.|Blood|2003Cited by 407
Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic MalignanciesMohamed L. Sorror, Rainer Storb, Brenda M. Sandmaier et al.|JAMA|2011Cited by 320